Impact of flavin-containing monooxygenase 3 and CYP2C19 genotypes on plasma disposition and adverse effects of voriconazole administered orally in immunocompromised patients-Reference-Cited by-同舟云学术

Impact of flavin-containing monooxygenase 3 and CYP2C19 genotypes on plasma disposition and adverse effects of voriconazole administered orally in immunocompromised patients

Published:2019-12 Issue:12 Volume:25 Page:1019-1025
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Yamada Takahiro,Mino Yasuaki,Naito Takafumi^ORCID,Kawakami Junichi

Funder

KAKENHI

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference32 articles.

1. Antifungal serum concentration monitoring: an update;Goodwin;J Antimicrob Chemother,2008

2. Voriconazole concentrations and outcome of invasive fungal infections;Miyakis;Clin Microbiol Infect,2010

3. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes;Pascual;Clin Infect Dis,2008

4. Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities;Tan;J Clin Pharmacol,2006

5. Voriconazole;Jeu;Clin Ther,2003

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Plasma Trough Concentration of Voriconazole and Voriconazole N-Oxide in Its Hepatotoxicity in Adult Patients;Drug Design, Development and Therapy;2024-08

2. Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole;Clinical and Translational Science;2024-07

3. Interaction of age and CYP2C19 genotypes on voriconazole steady-state trough concentration in Chinese patients;Pharmacogenetics and Genomics;2024-05-15

4. Impact of CYP2C19, CYP2C9, CYP3A4, and FMO3 Genetic Polymorphisms and Sex on the Pharmacokinetics of Voriconazole after Single and Multiple Doses in Healthy Chinese Subjects;The Journal of Clinical Pharmacology;2024-04-23

5. Contribution of voriconazole N‐oxide plasma concentration measurements to voriconazole therapeutic drug monitoring in patients with invasive fungal infection;Mycoses;2023-02-05